SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 57.32 |
| Enterprise Value ($M) | 47.56 |
| Book Value ($M) | 6.58 |
| Book Value / Share | 0.09 |
| Price / Book | 8.71 |
| NCAV ($M) | 0.26 |
| NCAV / Share | 0.00 |
| Price / NCAV | 223.03 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.96 |
| Return on Assets (ROA) | -0.75 |
| Return on Equity (ROE) | -1.35 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.03 |
| Current Ratio | 1.03 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 15.93 |
| Assets | 22.25 |
| Liabilities | 15.67 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 9.29 |
| Operating Income | -41.59 |
| Net Income | -40.67 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -36.33 |
| Cash from Investing | 0.03 |
| Cash from Financing | 10.24 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Bleichroeder LP | 9.99 | 0.00 | |
| 13G/A | Slate Path Capital LP | 1.40 | -61.75 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 45,174 | 259,743 | 17.39 | |
| 29,371 | 155,309 | 18.91 | |
| 26,854 | 93,207 | 28.81 | |
| 25,095 | 57,515 | 43.63 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CSBR – Champions Oncology, Inc. | CSCI – COSCIENS Biopharma Inc. |
| CTXR – Citius Pharmaceuticals, Inc. | CVKD – Cadrenal Therapeutics, Inc. |
| CYCC – Cyclacel Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io